Paper22802445
BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.
Banerjee C and 8 others. J Leukoc Biol, 2012. Cited by 218 papers, by iCite.
Cite this record
ConductScience Library. BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. Papers, record 22802445. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22802445
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Azepines | Major topic |
| HIV-1 | Major topic |
| Triazoles | Major topic |
| Virus Activation | Major topic |
| Virus Latency | Major topic |
| CD4-Positive T-Lymphocytes | |
| Cell Line | |
| Cell Proliferation | |
| Chromatin Assembly and Disassembly | |
| Cluster Analysis | |
| Gene Expression Regulation | |
| Gene Expression Regulation, Viral | |
| Humans | |
| Lymphocyte Activation | |
| Monocyte-Macrophage Precursor Cells | |
| Transcription, Genetic | |
| Transcriptome |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DA030156 | NIDA NIH HHS | United States | R01DA030156 | PubMed and NIH | NIH RePORTER |
| R01 AR055115 | NIAMS NIH HHS | United States | R01AR055115 | PubMed and NIH | NIH RePORTER |
| R56 DK090455 | NIDDK NIH HHS | United States | R56DK090455 | PubMed and NIH | NIH RePORTER |
| U19 AI096113 | NIAID NIH HHS | United States | U19AI096113 | PubMed and NIH | NIH RePORTER |
| P30 AI050410 | NIAID NIH HHS | United States | P30AI050410 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 23204259 | Editorial: JQ1: giving HIV-1 expression a boost by blocking bromodomains? | https://conductscience.org/library/papers/23204259 |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11403229 | OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion. | J Clin Immunol | 2001 | https://conductscience.org/library/papers/11403229 | PubMed |
| 2 | 15152190 | Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. | EMBO J | 2004 | https://conductscience.org/library/papers/15152190 | PubMed |
| 3 | 12805437 | Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo. | J Virol | 2003 | https://conductscience.org/library/papers/12805437 | PubMed |
| 4 | 20186346 | Antiretroviral intensification and valproic acid lack sustained effect on residual HIV-1 viremia or resting CD4+ cell infection. | PLoS One | 2010 | https://conductscience.org/library/papers/20186346 | PubMed |
| 5 | 21949397 | Targeting MYC dependence in cancer by inhibiting BET bromodomains. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21949397 | PubMed |
| 6 | 9144289 | Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. | Nature | 1997 | https://conductscience.org/library/papers/9144289 | PubMed |
| 7 | 17690245 | Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17690245 | PubMed |
| 8 | 17442680 | Negative elongation factor NELF represses human immunodeficiency virus transcription by pausing the RNA polymerase II complex. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17442680 | PubMed |
| 9 | 19265012 | The challenge of finding a cure for HIV infection. | Science | 2009 | https://conductscience.org/library/papers/19265012 | PubMed |
| 10 | 21889194 | BET bromodomain inhibition as a therapeutic strategy to target c-Myc. | Cell | 2011 | https://conductscience.org/library/papers/21889194 | PubMed |
| 11 | 19144703 | Determinants of the establishment of human immunodeficiency virus type 1 latency. | J Virol | 2009 | https://conductscience.org/library/papers/19144703 | PubMed |
| 12 | 9360926 | Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. | Science | 1997 | https://conductscience.org/library/papers/9360926 | PubMed |
| 13 | 18223296 | The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18223296 | PubMed |
| 14 | 14606959 | The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses. | BMC Cancer | 2003 | https://conductscience.org/library/papers/14606959 | PubMed |
| 15 | 20616270 | HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals. | Science | 2010 | https://conductscience.org/library/papers/20616270 | PubMed |
| 16 | 17376917 | Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1. | J Virol | 2007 | https://conductscience.org/library/papers/17376917 | PubMed |
| 17 | 20410271 | Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction. | J Virol | 2010 | https://conductscience.org/library/papers/20410271 | PubMed |
| 18 | 16051143 | Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. | Cell | 2005 | https://conductscience.org/library/papers/16051143 | PubMed |
| 19 | 12682019 | HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. | EMBO J | 2003 | https://conductscience.org/library/papers/12682019 | PubMed |
| 20 | 3313729 | Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. | Science | 1987 | https://conductscience.org/library/papers/3313729 | PubMed |
Cited by174
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 218 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42947143 | Virus-informed targeting of HIV reservoirs: Rev-dependent HIV Immunotherapy (RHIT). | Retrovirology | 2026 | https://conductscience.org/library/papers/42947143 | PubMed |
| 42922717 | Screening of epigenetic modifiers identifies novel host-directed agents that suppress HIV-1 replication in primary human macrophages. | bioRxiv | 2026 | https://conductscience.org/library/papers/42922717 | PubMed |
| 42059621 | Is the molecular microenvironment of the latent HIV reservoir predictable using deep learning approaches? | J Virol | 2026 | https://conductscience.org/library/papers/42059621 | PubMed |
| 41885112 | Latent HIV Reservoirs in the Central Nervous System: Mechanisms, Barriers, and Therapeutic Approaches. | ACS Infect Dis | 2026 | https://conductscience.org/library/papers/41885112 | PubMed |
| 41025857 | HIV proviral transcription and infectivity are enhanced by neddylation. | J Virol | 2025 | https://conductscience.org/library/papers/41025857 | PubMed |
| 40936906 | The role of Tat in HIV latency and reactivation. | Front Immunol | 2025 | https://conductscience.org/library/papers/40936906 | PubMed |
| 40666455 | Effects of Oxygen Atom Position in Linear Side Chains of Ansellone Analogues on HIV Latency-Reversing Activity. | ACS Med Chem Lett | 2025 | https://conductscience.org/library/papers/40666455 | PubMed |
| 40335477 | BRD4 modulator ZL0580 and LEDGINs additively block and lock HIV-1 transcription. | Nat Commun | 2025 | https://conductscience.org/library/papers/40335477 | PubMed |
| 40067013 | BET degraders reveal BRD4 disruption of 7SK and P-TEFb is critical for effective reactivation of latent HIV in CD4+ T-cells. | J Virol | 2025 | https://conductscience.org/library/papers/40067013 | PubMed |
| 39692477 | Tannic acid reactivates HIV-1 latency by mediating CBX4 degradation. | J Virol | 2025 | https://conductscience.org/library/papers/39692477 | PubMed |
| 39066325 | HIV Persistence, Latency, and Cure Approaches: Where Are We Now? | Viruses | 2024 | https://conductscience.org/library/papers/39066325 | PubMed |
| 38618911 | Zinc-chelating BET bromodomain inhibitors equally target islet endocrine cell types. | Am J Physiol Regul Integr Comp Physiol | 2024 | https://conductscience.org/library/papers/38618911 | PubMed |
| 38444369 | Effective and targeted latency reversal in CD4+ T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection. | Emerg Microbes Infect | 2024 | https://conductscience.org/library/papers/38444369 | PubMed |
| 38229743 | Chemical Catalysis Guides Structural Identification for the Major In Vivo Metabolite of the BET Inhibitor JQ1. | ACS Med Chem Lett | 2024 | https://conductscience.org/library/papers/38229743 | PubMed |
| 38140676 | Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure. | Viruses | 2023 | https://conductscience.org/library/papers/38140676 | PubMed |
| 37949879 | PRMT2 promotes HIV-1 latency by preventing nucleolar exit and phase separation of Tat into the Super Elongation Complex. | Nat Commun | 2023 | https://conductscience.org/library/papers/37949879 | PubMed |
| 37224601 | Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activity. | Eur J Med Chem | 2023 | https://conductscience.org/library/papers/37224601 | PubMed |
| 37212670 | Ponatinib Represses Latent HIV-1 by Inhibiting AKT-mTOR. | Antimicrob Agents Chemother | 2023 | https://conductscience.org/library/papers/37212670 | PubMed |
| 37201092 | Bromodomain-containing protein 9 activates proliferation and epithelial-mesenchymal transition of colorectal cancer via the estrogen pathway in vivo and in vitro. | J Gastrointest Oncol | 2023 | https://conductscience.org/library/papers/37201092 | PubMed |
| 37142850 | Targeting bromodomain-containing proteins: research advances of drug discovery. | Mol Biomed | 2023 | https://conductscience.org/library/papers/37142850 | PubMed |
Genes58
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22802445
GET https://conductscience.org/api/papers/v1/22802445/references?page=2